Saxagliptin
ATC Code
A10BH03
Saxagliptin
Definition
A potent, selective and competitive, cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Saxagliptin is metabolized into an, although less potent, active mono-hydroxy metabolite.
Also known as BMS-477118-11, SAXAGLIPTIN, Saxagliptin Hydrate, Saxagliptin Monohydrate — per NCIT
Also identified as
- ATC A10BH03 per RXNORM
- NCIT NCIT:C75983 per NCIT
- SCTID 443066009 per RXNORM
- SCTID 443087004 per RXNORM
- UNII 9GB927LAJW per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Diabetes mellitus type 2 | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Alimentary part of gastrointestinal system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Pancreas | may treat a disease of this organ | DERIVED · CC BY 4.0 |
2 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.